AR032519A1 - Compuestos - Google Patents

Compuestos

Info

Publication number
AR032519A1
AR032519A1 ARP020100273A ARP020100273A AR032519A1 AR 032519 A1 AR032519 A1 AR 032519A1 AR P020100273 A ARP020100273 A AR P020100273A AR P020100273 A ARP020100273 A AR P020100273A AR 032519 A1 AR032519 A1 AR 032519A1
Authority
AR
Argentina
Prior art keywords
compounds
relates
present
methylbenzylamino
imidazo
Prior art date
Application number
ARP020100273A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR032519A1 publication Critical patent/AR032519A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a nuevas formas cristalinas de la sal de mesilato de 2,3- dimetil-8-(2-etil-6-metilbencilamino)-imidazo[1,2-a]piridina-6-carboxamida. Además, la presente invencion se refiere también al uso de dichos compuestos para el tratamiento de desordenes gastrointestinales, a las composiciones farmacéuticas que los contienen y a los procedimientos para obtenerlos.
ARP020100273A 2001-02-01 2002-01-25 Compuestos AR032519A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100296A SE0100296D0 (sv) 2001-02-01 2001-02-01 New compounds

Publications (1)

Publication Number Publication Date
AR032519A1 true AR032519A1 (es) 2003-11-12

Family

ID=20282798

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100273A AR032519A1 (es) 2001-02-01 2002-01-25 Compuestos

Country Status (3)

Country Link
AR (1) AR032519A1 (es)
SE (1) SE0100296D0 (es)
WO (1) WO2002060441A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1565465A1 (en) 2002-11-19 2005-08-24 ALTANA Pharma AG 8-substituted imidazopyridines
CA2544325A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
WO2007043939A1 (en) * 2005-10-07 2007-04-19 Astrazeneca Ab Novel crystalline form of 3,5-dibromo-n- [(2s)-2-(-4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl] -n-methylbenzamide, modification a

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds

Also Published As

Publication number Publication date
WO2002060441A1 (en) 2002-08-08
SE0100296D0 (sv) 2001-02-01

Similar Documents

Publication Publication Date Title
ECSP088413A (es) Preparación y uso de derivados de tetrahidropirrolo[3,2-c]piridin-4-ona para el tratamiento de la obesidad, trastornos psiquiátricos y neurológicos
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
UY28376A1 (es) Agentes terapéuticos
UY27740A1 (es) Nuevos compuestos
WO2006107771A3 (en) PYRAZOLO[3,4-c]QUINOLINES, PYRAZOLO[3,4-c]NAPHTHYRIDINES, ANALOGS THEREOF, AND METHODS
CL2003002287A1 (es) COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
AR052447A1 (es) Etansulfonato de 1-(2-metipropil)-1h-imidazo[4,5-c] [1,5] naftiridin-4- amina y metansulfonato de 1-(2- metipropil)-1h-imidazo[4,5 -c] [1,5] naftiridin-4-amina
UY28510A1 (es) Compuestos quimicos
AR048912A1 (es) Inmunoglobulinas anti-nogo
CR6726A (es) Compuestos azapoliciclicos condensados con arilo
UY29781A1 (es) Compuestos diazaspiro sustituidos, sales farmacéuticamente aceptables, composiciones farmacéuticas que contienen los compuestos o sales, métodos de preparación y usos
CR9834A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la ezquizofrenia
WO2006107853A3 (en) Pyrazolopyridine-1,4-diamines and analogs thereof
AR054122A1 (es) Pirido[2,3-d]pirimidas utiles como inhibidores de hcv, y metodos para la preparacion de las mismas
HN2002000154A (es) Azaindoles
CY1113047T1 (el) Νεα κρυσταλλικη και αμορφη μορφη μιας ενωσης τριαζολο (4,5-d) πυριμιδινης
EA200700144A1 (ru) Производные пиридопиримидина, их получение, их применение в терапии
EA200801327A1 (ru) Новый способ и композиции
HUP0402270A2 (hu) [1,2,4]Triazolo[1,5-c]pirimidin-5-il-aminok mint adenozin A2a receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények
CR9643A (es) Derivados de n-(arilalquil)-1h-pirrolopiridina-2-carboxamidas, su preparacion y su aplicacion en terapeutica
AR028250A1 (es) Imidazo [1,5-a]-pirido [3,2-e]-pirazinonas, la utilizacion de dichos compuestos y sus sales para la preparacion de medicamentos y los medicamentos asi preparados
HN2002000365A (es) Lactamas como antagonistas de taquiquininas
GT200500340A (es) Derivados de octahidropirrolo [3,4-c] pirrol
UY28377A1 (es) Agentes terapeuticos
SI1869038T1 (sl) Substituirane 5,6,7,8-tetrahidro-imidazo(1,2-a)piridin-2-ilaminske spojine in njihova uporaba za pripravo zdravil

Legal Events

Date Code Title Description
FB Suspension of granting procedure